lundi 12 février 2018

Onco Actu du 12 février 2018

1. Biologie

TSRI scientists take big step toward stopping cancer metastasis [The Scripps Research Institute]

Could Darwin help us outsmart cancer? [Institute of Cancer Research]

3.1 Prévention - Tabac

Tobacco firms in France cheated nicotine tests: anti-smoking body [Reuters]

3.1.1 Prévention - Tabac - e-cigs

Even without nicotine, e-cigarettes can still damage lungs [Reuters]

3.3 Prévention - Vaccins

We’re two shots away from preventing HPV-related cancers [STAT]

3.8 Prévention - Alimentation

Asparagus and breast cancer study: What you need to know [HealthNewsReview]

4.10 Dép., diag. & prono. - FDA, EMA, NICE,...

Scans could help tailor pancreatic cancer treatment [Cancer Research UK]

5.12 Immunothérapies

Oncolytic Virus Therapy: Using Tumor-Targeting Viruses to Treat Cancer [NCI]

The Next Immuno-oncology Frontier? [In the Pipeline]

5.12.1 Immunothérapies - partenariats

Pieris, Seattle Genetics pen $1.2B biobucks pact for next-gen cancer drugs [FierceBiotech]

Seattle Genetics and Pieris Pharmaceuticals Announce Multi-Program Immuno-Oncology Collaboration [Seattle Genetics]

Seattle Genetics seeds a new immuno-oncology collaboration with the protein explorers at Pieris [EndPoints]

5.3 Traitements - FDA, EMA, NICE...

Trump Rules: F.D.A. Chief Goes Against the Administration Stereotype [NY Times]

5.3.4 Traitements - AMM (FDA, EMA,...)

FDA Approves Abiraterone Acetate in Combination with Prednisone for High-Risk Metastatic Castration-Sensitive Prostate Cancer [ESMO]

5.4 Traitements - Economie

Liver cancer patients barred from NHS access to Bayer’s Stivarga [PharmaTimes]

NICE asks Tesaro to submit CDF application for Zejula [PharmaTimes]

Roche wins UK watchdog's nod for lymphoma drug after initial snub [Reuters]

Lower Drug Prices: New Proposals Carry Lots of Promises [NY Times]

5.5.3 ASCO (prostate)

Apalutamide delays spread of certain prostate cancers in trial [Cancer Research UK]

5.5.9 ASCO (autres organes)

AVEO Oncology and EUSA Pharma Announce Encouraging Preliminary Results from Phase 2 Portion of the TiNivo Study in Renal Cell Carcinoma [Aveo]

6.10.1 Politiques (USA)

ASCO Applauds Congress for Making MACRA Work, Committing to Cancer Research in Latest Budget Bill [ASCO]